BSE filing, NSE: HINDPETRO. Summary written from the filing by ALFA Finder's alert engine.
Hindustan Petroleum Corporation Ltd: key numbers
- Share price
- ₹347.15
- Market cap
- ₹73,867 Cr
- Revenue (annual)
- ₹4,41,771 Cr
- Net profit (annual)
- ₹18,047 Cr
- P/E (TTM)
- 51.4×Sector 18.3×
- Promoter holding
- 54.90%+0.00% QoQ
- FII holding
- 13.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hindustan Petroleum Corporation Ltd
All →Hindustan Petroleum Corporation Earnings Call Transcript: Key Takeaways
HPCL staged a sharp recovery from Q1 losses, driven by strong physical refinery performance and stabilizing marketing margins, despite persistent high crude price volatility.
Hindustan Petroleum Corporation Earnings Call Transcript: Key Takeaways
HPCL reported Revenue of ₹ 2,84,267 Cr for H1 FY27, however, incurred a Net Loss of ₹ 8,044 Cr despite high GRM of US$ 27.89/bbl.
Hindustan Petroleum Corporation Results Update
HPCL released an investor handout summarizing its financial and operational performance for the quarter and half-year ended September 30, 2026.
Hindustan Petroleum Corporation Q2 FY27 Results: Net Profit ₹3,625 Cr, Down 6.1% YoY
Hindustan Petroleum Corporation Ltd reported revenue from operations of ₹139,114 Cr (+26.0% YoY) and net profit of ₹3,625 Cr (-6.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹3,625 Cr · -6.1% YoY
Hindustan Petroleum Corporation Board Meeting Date
Hindustan Petroleum Corporation Limited has scheduled a board meeting for October 22, 2026, to consider its unaudited financial results for the quarter and half-year.
Hindustan Petroleum Corporation Management Change
Hindustan Petroleum Corporation Limited announced the superannuation of Shri N Baladhandayuthapani, Executive Director. He stepped down from the Senior Management Team effective October 1, 2026.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.